Affordable Access

Access to the full text

Genetic analysis of cardiac-specific transcription factors reveals insights into congenital heart disease

Authors
  • Reamon-Buettner, S. M.1
  • Borlak, J.1, 2
  • 1 Fraunhofer Institute of Toxicology and Experimental Medicine, Drug Research and Medical Biotechnology, Hannover, Germany , Hannover
  • 2 Fraunhofer Institute of Toxicology and Experimental Medicine, Drug Research and Medical Biotechnology, Nikolai-Fuchs-Strasse 1, Hannover, 30625, Germany , Hannover
Type
Published Article
Journal
Monatsschrift Kinderheilkunde
Publisher
Springer-Verlag
Publication Date
Nov 01, 2004
Volume
152
Issue
11
Pages
1183–1188
Identifiers
DOI: 10.1007/s00112-004-1044-7
Source
Springer Nature
Keywords
License
Yellow

Abstract

Heart development is complex and requires the sequential and timely interplay of regulatory master proteins, notably several transcription factors. Germline mutations in the human transcription factor genes such as NKX2-5, TBX5 and GATA4 are associated with cardiac anomalies. Familial cases so far studied have different mutations and no mutation can be associated with a specific clinical phenotype. Many cases of CHD come from unaffected family members. We searched for sequence alterations in cardiac specific transcription factor genes that would lead to loss-of-function of the protein in 68 malformed hearts from the Leipzig heart collection. By direct DNA sequencing, we obtained mutations in several transcription factors e.g. NKX2-5, TBX5 and GATA4 in the diseased heart tissues, which were mainly absent in normal heart tissues of the same CHD patients. We also observed multiple mutations in patients, multiple haplotypes, and detection of mutations in Down syndrome patients, all suggesting somatic origin of mutations and genomic instability in the diseased cardiac tissues of patients with CHD. Somatic mutations may provide an alternate mechanism of disease.

Report this publication

Statistics

Seen <100 times